Skip to Main Content
Home
Search
Study Topics
Glossary
Study 19 of 2431 for search of:
received on or after 11/14/2008
Previous Study
Return to Search Results
Next Study
Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
Therapy Optimization in Multiple Sclerosis (MS) (TOP MS)
This study is currently recruiting participants.
Study NCT00819000. Last updated on January 7, 2009.
Information provided by Teva Pharmaceutical Industries
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Multiple Sclerosis
Additional conditions recognized in this trial
Sclerosis
More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Demyelinating Autoimmune Diseases, CNS
Demyelinating Diseases
Immune System Diseases
Nervous System Diseases
Pathologic Processes
Additional drug interventions recognized in this trial
Copolymer 1
Interferon-beta
More general drug interventions related to this trial
Adjuvants, Immunologic
Anti-Infective Agents
Antineoplastic Agents
Antiviral Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Teva Pharmaceutical Industries
Back to top of Main Content